drosperinone

This page contains recent news articles, when available, and an overview of drosperinone but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

De piltest  -  ‎Dec 30, 2009‎
De laatste jaren zijn er pillen op de markt gekomen met als progestageen drosperinone. Omdat dit hormoon net een vochtafdrijvend effect op het lichaam heeft ... Goed Gevoel

Bayer Says Swissmedic Sees No Higher Risk for Drosperinone Pills  -  ‎Oct 22, 2009‎
Oct. 22 (Bloomberg) -- Bayer AG said Switzerland's drug regulator Swissmedic sees no increased risk of deadly blood clots from its ... Bloomberg

Suicide Blamed on Acne Drugs  -  ‎Oct 30, 2009‎
YAZ (drosperinone and ethinyl estradiol), a birth control drug, has been the subject of dozens of lawsuits that claim it can cause life-threatening ... Courthouse News Service

Despite Yaz, Yasmin Problems Sales Continue to Climb  -  ‎Oct 28, 2009‎
The FDA indicated the drug giant sent out potentially low-quality batches of drosperinone and attempted to justify the shipments by only looking at the ... AboutLawsuits.com

NuvaRing: at least as reliable as the pill yet with once-a-month...  -  Mar 11, 2005
...[2] In the other trial against a pill containing 30mcg EE and 3.0 mg drosperinone a Pearl Index of 0.25 was reported for NuvaRing and 0.99 for the combined ... Medical News Today - Medical News Today (press release)

Hormone Replacement Therapy; Estrogen therapy regimens have …  -  Feb 7, 2005
..."Doses in the oral estradiol treatment groups (continuous combined therapy) were 1 mg 17-beta-estradiol + 1 mg drosperinone or 1 mg 17-beta-estradiol + 2 mg ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones

Center for Clinical & Basic Res., Ballerup; Estrogen therapy regimens...  -  Feb 9, 2005
..."Doses in the oral estradiol treatment groups (continuous combined therapy) were 1 mg 17-beta-estradiol + 1 mg drosperinone or 1 mg 17-beta-estradiol + 2 mg ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

Hormone Replacement Therapy; Estrogen therapy regimens have …  -  Feb 12, 2005
..."Doses in the oral estradiol treatment groups (continuous combined therapy) were 1 mg 17-beta-estradiol + 1 mg drosperinone or 1 mg 17-beta-estradiol + 2 mg ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Siklus reproduksi berujung depresi  -  Apr 23, 2008
Hormon drosperinone dipercaya bisa menjadi senjata perempuan dalam ... Sampai saat ini, drosperinone dapat ditemukan dalam kandungan pil KB inovasi terbaru ... Portal CBN

Women with PCOS reduced weight with lifestyle modification  -  Jun 16, 2008
They assigned 36 participants to an oral contraceptive (30 mcg ethinyl estradiol, 3.0 mg drosperinone) and either 2000 mg/day of metformin or placebo, ... Endocrine Today

Extended Oral Contraceptives Decrease Premenstrual Symptoms  -  Apr 15, 2007
Conclusion: The use of a 168-day extended regimen of drosperinone in combination with ethinyl estradiol decreased premenstrual symptoms compared with a ... AAFP News Now

Zero Tolerance Anti-Doping Newsletter  -  Jan 1, 2006
Clarifies that drosperinone, a progestative with mild diuretic properties, is not prohibited (as indicated in the Explanatory Note of the 2005 Prohibited ... USA Track and Field

In acne therapy hormonal therapy plays role as adjunct.  -  Nov 1, 2006
Phase III studies investigating Yasmin (ethinyl estradiol/drosperinone, Berlex) have recently been completed. That agent is unique as its progestin ... $4.95 - Dermatology Times - ECNext

Article: Bayer Healthcare and Intendis Inc. form alliance to promote...  -  Aug 1, 2007
YAZ(R) (drosperinone ... December 31, 2006. YAZ(R) is a registered trademark of Bayer HealthCare Pharmaceuticals ... ... Pay-Per-View - Dermatology Nursing - HighBeam Research

Press Release: Bayer HealthCare and Intendis Announce Strategic …  -  May 7, 2007
YAZ(R) (drosperinone ... December 31, 2006. YAZ(R) is a registered trademark of Bayer HealthCare Pharmaceuticals ... ... Pay-Per-View - PR Newswire - HighBeam Research

Le donne sportive lo fanno meglio e corrono minori rischi cardiovascol...  -  Dec 9, 2008
Le pillole anticoncezionali, in particolare quelle che contengono drosperinone, possono infatti favorire la performance sportiva, anche ad alto livello, ... Preview

Press Release: Watson Files FDA Application for Generic YAZ(R). - PR ...  -  Nov 7, 2007
YAZ(R) (drosperinone and ethinyl estradiol tablets) is indicated for the prevention of pregnancy. Forward-Looking Statement ... Pay-Per-View - PR Newswire - HighBeam Research

Scriptlines: WADA list 2006.(World Anti-Doping Agency's updated list...  -  Oct 15, 2005
Other modifications include clarification that drosperinone, a progestogen with mild diuretic properties, is not banned, and lifting the need for a ... $4.95 - Chemist & Druggist - ECNext

Ecco la lista delle sostanze e metodi proibiti in vigore dal 1°...  -  Jul 18, 2008
...triamterene, e altre sostanze con struttura chimica similare o un effetto(i) biologico(i) simile(i), (fa eccezione il drosperinone che non è vietato). ... Dica 33

NUVARING Organon clinical data (contraception).(Organon …  -  Mar 21, 2005
The second trial compared NUVARING with an oral pill containing 30 mcg EE and 3.0 mg drosperinone; in the NUVARING group a Pearl Index of 0.25 was recorded ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy